Universe Pharmaceutical Class AUPC
13F holders, Q3 2025 (September 30)2holders +1
2new positions
0sold out
$4.52avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Universe Pharmaceutical Class A (UPC) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 0 sold out. The largest holders were Osaic Holdings, Inc. ($9K) and UBS Group AG ($4).
- Company
- Universe Pharmaceutical Class A
- CUSIP
- G9442G138
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $9K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q3 2025: 2,001 shares bought, net +2,001 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Osaic Holdings, Inc. | 0.00% | New | 2,000 | $9K |
| UBS Group AG | 0.00% | New | 1 | $4 |
"% of holder's portfolio" is UPC's weight in each manager's 13F, not the share of Universe Pharmaceutical Class A the manager owns.